Year archive

Revive Therapeutics Ltd. — 2025 filings

All 40 regulatory filings released by Revive Therapeutics Ltd. (RVV) in 2025, sourced directly from the official regulator.

40 Filings

2025 Period

2025 filings (40)

Filing	Released	Lang
News release - English.pdf Regulatory Filings	2025-12-15	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-11-28	English
Interim MD&A - English.pdf Regulatory Filings	2025-11-28	English
Interim financial statements/report – English.pdf Regulatory Filings	2025-11-28	English
News release - English.pdf Regulatory Filings	2025-11-21	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2025-10-28	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2025-10-28	English
Annual MD&A - English.pdf Management Reports	2025-10-28	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-10-28	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-10-28	English
Audited annual financial statements – English.pdf Audit Report / Information FY 2025	2025-10-28	English
News release - English.pdf Capital/Financing Update	2025-09-19	English
News release - English.pdf Capital/Financing Update	2025-09-06	English
News release - English.pdf Regulatory Filings	2025-08-12	English
Notice.pdf Regulatory Filings	2025-08-12	English
News release - English.pdf Capital/Financing Update	2025-07-31	English
News release - English.pdf Regulatory Filings	2025-07-08	English
News release - English.pdf Regulatory Filings	2025-06-26	English
News release - English.pdf Regulatory Filings	2025-06-04	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings Q1 2025	2025-05-30	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-05-30	English
Interim MD&A - English.pdf Management Reports	2025-05-30	English
Interim financial statements/report – English.pdf Interim / Quarterly Report 9M 2025	2025-05-30	English
News release - English.pdf Regulatory Filings	2025-05-12	English
Report of exempt distribution (45-106F1).pdf Regulatory Filings	2025-05-08	English
News release - English.pdf Share Issue/Capital Change	2025-04-21	English
News release - English.pdf Regulatory Filings	2025-04-10	English
News release - English.pdf M&A Activity	2025-04-01	English
News release - English.pdf Declaration of Voting Results & Voting Rights Announcements	2025-03-19	English
News release - English.pdf M&A Activity	2025-03-03	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-03-01	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-03-01	English
Interim MD&A - English.pdf Management Reports	2025-03-01	English
Interim financial statements/report – English.pdf Interim / Quarterly Report H1 2025	2025-03-01	English
Other.pdf Regulatory Filings	2025-02-14	English
News release - English.pdf Regulatory Filings	2025-02-03	English
Notice of the meeting and record date (amended) - English.pdf Regulatory Filings	2025-01-28	English
Statement of executive compensation (form 51-102F6) - English.pdf Remuneration Information	2025-01-08	English
News release - English.pdf Regulatory Filings	2025-01-08	English
Notice of the meeting and record date - English.pdf Proxy Solicitation & Information Statement	2025-01-02	English

Filings by year

2026 5 filings
2025 40 filings
2024 38 filings
2023 49 filings
2022 45 filings
2021 79 filings
2020 68 filings
2019 35 filings
2018 33 filings
2017 25 filings